Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Leuk Lymphoma. 2017 Nov 29;59(8):1861–1870. doi: 10.1080/10428194.2017.1403601

Figure 2:

Figure 2:

(A-B) Probabilities of event free survival (A) and overall survival (B) for patients with chemotherapy sensitive disease (defined as CR or PR at time of ASCT) compared to chemotherapy resistant disease (defined as SD or PD). (C-D) Probabilities of event free survival (C) and overall survival (D) for patients transplanted in 1989–1997 compared to 1998–2013. (E-F) Probabilities of event free survival (E) and overall survival (F) based on R-CHIPS.